'Well, It's the Risk of the Unknown… Right?': A Qualitative Study of Perceived Risks and Benefits of HIV Cure Research in the United States

Autor: Stuart Rennie, Alasdair Burton, Joseph D. Tucker, Loreen Willenberg, Sandra B. Greene, Laurie Sylla, David Evans, Bryan J. Weiner, Lynda Dee, Jeff Taylor, Karine Dubé, Asheley Cockrell Skinner
Jazyk: angličtina
Rok vydání: 2017
Předmět:
RNA viruses
Male
0301 basic medicine
Cell Transplantation
Cancer Treatment
Social Sciences
lcsh:Medicine
HIV Infections
Pathology and Laboratory Medicine
Grounded theory
0302 clinical medicine
Immunodeficiency Viruses
Sociology
Ethicists
Informed consent
Medicine and Health Sciences
Blood and Lymphatic System Procedures
030212 general & internal medicine
lcsh:Science
Qualitative Research
Clinical Trials as Topic
Social Research
Multidisciplinary
Community engagement
Stem Cell Therapy
Middle Aged
Research Personnel
3. Good health
Social research
Oncology
Medical Microbiology
Viral Pathogens
Viruses
Female
Pathogens
Thematic analysis
Risk assessment
Attitude to Health
Research Article
Adult
medicine.medical_specialty
Drug Research and Development
Patients
Anti-HIV Agents
Surgical and Invasive Medical Procedures
Microbiology
Risk Assessment
Interviews as Topic
Young Adult
03 medical and health sciences
Adverse Reactions
Drug Therapy
Environmental health
Retroviruses
medicine
Humans
Microbial Pathogens
Pharmacology
Clinical Genetics
Transplantation
business.industry
Research
Lentivirus
lcsh:R
Organisms
Administrative Personnel
Biology and Life Sciences
HIV
Genetic Therapy
United States
Cure Study
030104 developmental biology
Family medicine
lcsh:Q
business
Stem Cell Transplantation
Qualitative research
Zdroj: PLoS ONE, Vol 12, Iss 1, p e0170112 (2017)
PLoS ONE
ISSN: 1932-6203
Popis: Introduction Biomedical research towards an HIV cure is advancing in the United States and elsewhere, yet little is known about perceptions of risks and benefits among potential study participants and other stakeholders. We conducted a qualitative study to explore perceived risks and benefits of investigational HIV cure research among people living with HIV (PLWHIV), biomedical HIV cure researchers, policy-makers and bioethicists. Methods We conducted a qualitative research study using in-depth interviews with a purposive sample of PLWHIV, biomedical HIV cure researchers, policy-makers and bioethicists in 2015–2016. We analysed interview transcripts using thematic analysis anchored in grounded theory. Results We conducted and analyzed 36 key informant interviews. Qualitative analysis revealed four main findings. 1) Potential HIV cure study volunteers noted needing more information and education about the potential risks of HIV cure research. 2) Biomedical HIV cure researchers, policy-makers and bioethicists showed less awareness of social and financial risks of HIV cure research than PLWHIV. 3) Most respondents across the different categories of informants identified some risks that were too great to be acceptable in HIV cure research, although a subset of PLWHIV did not place an upper limit on acceptable risk. 4) PLWHIV showed a better awareness of potential psychological benefits of participating in HIV cure research than other groups of stakeholders. Conclusion Our research suggests that PLWHIV have a variable understanding of the individual risks, sometimes substantial, associated with participating in biomedical HIV cure research studies. Community engagement and increased research literacy may help improve community understanding. Intensive informed consent procedures will be necessary for ethical study implementation. The current state of HIV cure research offers greater potential benefits to society than to participants. There is likely to be disagreement among regulators, researchers, clinicians, and potential participants about what constitutes acceptable risk for HIV cure studies.
Databáze: OpenAIRE